Wenzel M - Search Results

1

Differential subcellular localization of functionally divergent survivin splice variants.

Mahotka C, Liebmann J, Wenzel M, Suschek CV, Schmitt M, Gabbert HE, Gerharz CD. Mahotka C, et al. Among authors: wenzel m. Cell Death Differ. 2002 Dec;9(12):1334-42. doi: 10.1038/sj.cdd.4401091. Cell Death Differ. 2002. PMID: 12478470

2

Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.

Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD. Mahotka C, et al. Among authors: wenzel m. Cancer Res. 1999 Dec 15;59(24):6097-102. Cancer Res. 1999. PMID: 10626797

3

Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.

Ramp U, Dejosez M, Mahotka C, Czarnotta B, Kalinski T, Wenzel M, Lorenz I, Müller M, Krammer P, Gabbert HE, Gerharz CD. Ramp U, et al. Among authors: wenzel m. Br J Cancer. 2000 Jun;82(11):1851-9. doi: 10.1054/bjoc.2000.1155. Br J Cancer. 2000. PMID: 10839301 Free PMC article.

4

Amphotericin B severely affects expression and activity of the endothelial constitutive nitric oxide synthase involving altered mRNA stability.

Suschek CV, Bonmann E, Kleinert H, Wenzel M, Mahotka C, Kolb H, Förstermann U, Gerharz CD, Kolb-Bachofen V. Suschek CV, et al. Among authors: wenzel m. Br J Pharmacol. 2000 Oct;131(3):473-81. doi: 10.1038/sj.bjp.0703576. Br J Pharmacol. 2000. PMID: 11015297 Free PMC article.

5

Novel survivin-related members of the inhibitor of apoptosis (IAP) family.

Wenzel M, Mahotka C, Krieg A, Bachmann A, Schmitt M, Gabbert HE, Gerharz CD. Wenzel M, et al. Cell Death Differ. 2000 Jul;7(7):682-3. doi: 10.1038/sj.cdd.4400691. Cell Death Differ. 2000. PMID: 11023343 No abstract available.

6

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.

Mahotka C, Krieg T, Krieg A, Wenzel M, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD. Mahotka C, et al. Among authors: wenzel m. Int J Cancer. 2002 Jul 1;100(1):30-6. doi: 10.1002/ijc.10450. Int J Cancer. 2002. PMID: 12115583 Free article.

7

TRAIL-beta and TRAIL-gamma: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential.

Krieg A, Krieg T, Wenzel M, Schmitt M, Ramp U, Fang B, Gabbert HE, Gerharz CD, Mahotka C. Krieg A, et al. Among authors: wenzel m. Br J Cancer. 2003 Mar 24;88(6):918-27. doi: 10.1038/sj.bjc.6600772. Br J Cancer. 2003. PMID: 12644830 Free PMC article.

8

Screening for renal carcinoma associated mutations in the von Hippel-Lindau tumor suppressor gene by temperature gradient gel electrophoresis.

Wenzel M, Enczmann J, Uhrberg M, Hernández A, Wiese U, Ackermann R, Schmitz-Draeger B, Ebert T, Wernet P. Wenzel M, et al. Electrophoresis. 1997 Jan;18(1):45-51. doi: 10.1002/elps.1150180109. Electrophoresis. 1997. PMID: 9059819

9

Inverse Stage Migration in Radical Prostatectomy-A Sustaining Phenomenon.

Hoeh B, Preisser F, Mandel P, Wenzel M, Humke C, Welte MN, Müller M, Köllermann J, Wild P, Kluth LA, Roos FC, Chun FKH, Becker A. Hoeh B, et al. Among authors: wenzel m. Front Surg. 2021 Mar 1;8:612813. doi: 10.3389/fsurg.2021.612813. eCollection 2021. Front Surg. 2021. PMID: 33732728 Free PMC article.

10

Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma.

Nocera L, Stolzenbach LF, Ruvolo CC, Wenzel M, Tian Z, Rosiello G, Bravi CA, Candela L, Basile G, Larcher A, Shariat SF, Bertini R, Capitanio U, Salonia A, Montorsi F, Briganti A, Karakiewicz PI. Nocera L, et al. Among authors: wenzel m. Eur J Surg Oncol. 2021 May;47(5):1187-1190. doi: 10.1016/j.ejso.2020.10.040. Epub 2020 Nov 5. Eur J Surg Oncol. 2021. PMID: 33168336

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

738 results

Search Page